324 related articles for article (PubMed ID: 18254226)
21. Intermittent androgen replacement for intense hypogonadism symptoms in castrated patients.
Ferreira U; Leitao VA; Denardi F; Matheus WE; Stopiglia RM; Netto NR
Prostate Cancer Prostatic Dis; 2006; 9(1):39-41. PubMed ID: 16276352
[TBL] [Abstract][Full Text] [Related]
22. [Erectile dysfunction and obstructive sleep apnea syndrome].
Zhuravlev VN; Frank MA; Gomzhin AI
Urologiia; 2008; (2):35, 37-9. PubMed ID: 18572768
[TBL] [Abstract][Full Text] [Related]
23. Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations.
Morales A; Black AM; Emerson LE
BJU Int; 2009 Jan; 103(1):62-4. PubMed ID: 18671790
[TBL] [Abstract][Full Text] [Related]
24. Androgen pattern in patients with type 2 diabetes-associated erectile dysfunction: impact of metabolic control.
El-Sakka AI; Sayed HM; Tayeb KA
Urology; 2009 Sep; 74(3):552-9. PubMed ID: 19592073
[TBL] [Abstract][Full Text] [Related]
25. The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer.
Klotz L; Boccon-Gibod L; Shore ND; Andreou C; Persson BE; Cantor P; Jensen JK; Olesen TK; Schröder FH
BJU Int; 2008 Dec; 102(11):1531-8. PubMed ID: 19035858
[TBL] [Abstract][Full Text] [Related]
26. The use of drugs Impaza and Nebido in the treatment of erectile dysfunction in patients with type 2 diabetes mellitus of reproductive age.
Mehtiyev T
Georgian Med News; 2013 Jun; (219):61-5. PubMed ID: 23863213
[TBL] [Abstract][Full Text] [Related]
27. The prevalence of erectile dysfunction among Brazilian men screened for prostate cancer.
Paranhos M; Antunes A; Andrade E; Freire G; Srougi M
BJU Int; 2009 Oct; 104(8):1130-3. PubMed ID: 19426190
[TBL] [Abstract][Full Text] [Related]
28. [Serum and salivary testosterone levels in erectile dysfunction].
Corradi G; Szathmári M
Orv Hetil; 1998 Aug; 139(34):2021-4. PubMed ID: 9745307
[TBL] [Abstract][Full Text] [Related]
29. Testosterone supplementation for erectile dysfunction: results of a meta-analysis.
Jain P; Rademaker AW; McVary KT
J Urol; 2000 Aug; 164(2):371-5. PubMed ID: 10893588
[TBL] [Abstract][Full Text] [Related]
30. Testosterone therapy in men.
Theodoraki A; Bouloux PM
Menopause Int; 2009 Jun; 15(2):87-92. PubMed ID: 19465676
[TBL] [Abstract][Full Text] [Related]
31. Type 2 diabetes-associated androgen alteration in patients with erectile dysfunction.
El-Sakka AI; Sayed HM; Tayeb KA
Int J Androl; 2008 Dec; 31(6):602-8. PubMed ID: 17877718
[TBL] [Abstract][Full Text] [Related]
32. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.
Traish AM; Guay A; Feeley R; Saad F
J Androl; 2009; 30(1):10-22. PubMed ID: 18641413
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of erectile dysfunction in patients with plastic induration of the penis].
Sokol'shchik MM; Gagarina SV; Petrovich RIu; Sadakova IV
Urologiia; 2008; (1):41-4. PubMed ID: 18649679
[TBL] [Abstract][Full Text] [Related]
34. Androgen deficiency symptoms in testicular cancer survivors are associated with sexual problems but not with serum testosterone or therapy.
Lackner JE; Koller A; Schatzl G; Marberger M; Kratzik C
Urology; 2009 Oct; 74(4):825-9. PubMed ID: 19589582
[TBL] [Abstract][Full Text] [Related]
35. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic.
Corona G; Mannucci E; Petrone L; Ricca V; Balercia G; Mansani R; Chiarini V; Giommi R; Forti G; Maggi M
Int J Impot Res; 2006; 18(2):190-7. PubMed ID: 16136189
[TBL] [Abstract][Full Text] [Related]
36. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance.
Traish AM; Saad F; Guay A
J Androl; 2009; 30(1):23-32. PubMed ID: 18772488
[TBL] [Abstract][Full Text] [Related]
37. [Hormonal control of sexual behavior in males and endocrinologic causes of sexual dysfunction].
Manieri C; Di Bisceglie C; Tagliabue M; Fornengo R; Zumpano E
Minerva Endocrinol; 1997 Jun; 22(2):37-43. PubMed ID: 9304046
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of erectile disorders with androgens: When? How?].
Tostain J; Legon C; Ludot T; Castro R; Li GR
Prog Urol; 1997 Apr; 7(2):314-9. PubMed ID: 9264778
[TBL] [Abstract][Full Text] [Related]
39. Prostate cancer after exogenous testosterone replacement therapy in a patient with pituitary insufficiency.
Halland A; Jønler M; Pedersen KV
Scand J Urol Nephrol; 2005; 39(1):87-8. PubMed ID: 15764279
[TBL] [Abstract][Full Text] [Related]
40. Is testosterone treatment good for the prostate? Study of safety during long-term treatment.
Feneley MR; Carruthers M
J Sex Med; 2012 Aug; 9(8):2138-49. PubMed ID: 22672563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
